289 related articles for article (PubMed ID: 38540100)
1. The Application of Emodin Treatment on Nasopharyngeal Carcinoma Therapy.
Wu CC; Chen MS; Chen JY
Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540100
[TBL] [Abstract][Full Text] [Related]
2. Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis.
Wu CC; Chen MS; Cheng YJ; Ko YC; Lin SF; Chiu IM; Chen JY
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31731581
[TBL] [Abstract][Full Text] [Related]
3. Emodin suppresses the nasopharyngeal carcinoma cells by targeting the chloride channels.
Ma L; Yang Y; Yin Z; Liu M; Wang L; Chen L; Zhu L; Yang H
Biomed Pharmacother; 2017 Jun; 90():615-625. PubMed ID: 28411554
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
[TBL] [Abstract][Full Text] [Related]
5. Nasopharyngeal carcinoma: A review of current updates.
Wu L; Li C; Pan L
Exp Ther Med; 2018 Apr; 15(4):3687-3692. PubMed ID: 29556258
[TBL] [Abstract][Full Text] [Related]
6. Etiological factors of nasopharyngeal carcinoma.
Tsao SW; Yip YL; Tsang CM; Pang PS; Lau VM; Zhang G; Lo KW
Oral Oncol; 2014 May; 50(5):330-8. PubMed ID: 24630258
[TBL] [Abstract][Full Text] [Related]
7. Novel therapy for nasopharyngeal carcinoma--where are we.
Tsang J; Lee VH; Kwong DL
Oral Oncol; 2014 Sep; 50(9):798-801. PubMed ID: 24462373
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma.
Tan R; Phua SKA; Soong YL; Oon LLE; Chan KS; Lucky SS; Mong J; Tan MH; Lim CM
Cancer Commun (Lond); 2020 Nov; 40(11):564-585. PubMed ID: 32989921
[TBL] [Abstract][Full Text] [Related]
9. High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
Hui KF; Chan TF; Yang W; Shen JJ; Lam KP; Kwok H; Sham PC; Tsao SW; Kwong DL; Lung ML; Chiang AKS
Int J Cancer; 2019 Jun; 144(12):3031-3042. PubMed ID: 30536939
[TBL] [Abstract][Full Text] [Related]
10. The Health Benefits of Emodin, a Natural Anthraquinone Derived from Rhubarb-A Summary Update.
Stompor-Gorący M
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502424
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
[TBL] [Abstract][Full Text] [Related]
12. Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma.
Hau PM; Lung HL; Wu M; Tsang CM; Wong KL; Mak NK; Lo KW
Front Oncol; 2020; 10():600. PubMed ID: 32528868
[TBL] [Abstract][Full Text] [Related]
13. Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV.
Ahmed N; Abusalah MAHA; Farzand A; Absar M; Yusof NY; Rabaan AA; AlSaihati H; Alshengeti A; Alwarthan S; Alsuwailem HS; Alrumaih ZA; Alsayyah A; Yean CY
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676626
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin Inhibits Cancer Stem Cells and Sensitizes to Chemo- and Photodynamic Therapy in Nasopharyngeal Carcinoma.
Peng Y; He G; Tang D; Xiong L; Wen Y; Miao X; Hong Z; Yao H; Chen C; Yan S; Lu L; Yang Y; Li Q; Deng X
J Cancer; 2017; 8(9):1655-1664. PubMed ID: 28775785
[TBL] [Abstract][Full Text] [Related]
15. Nutlin-3, A p53-Mdm2 Antagonist for Nasopharyngeal Carcinoma Treatment.
Yee-Lin V; Pooi-Fong W; Soo-Beng AK
Mini Rev Med Chem; 2018; 18(2):173-183. PubMed ID: 28714398
[TBL] [Abstract][Full Text] [Related]
16. Systematic comparison of plasma EBV DNA, anti-EBV antibodies and miRNA levels for early detection and prognosis of nasopharyngeal carcinoma.
Tan LP; Tan GW; Sivanesan VM; Goh SL; Ng XJ; Lim CS; Kim WR; Mohidin TBBM; Mohd Dali NS; Ong SH; Wong CY; Sawali H; Yap YY; Hassan F; Pua KC; Koay CE; Ng CC; Khoo AS;
Int J Cancer; 2020 Apr; 146(8):2336-2347. PubMed ID: 31469434
[TBL] [Abstract][Full Text] [Related]
17. Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China.
Ji MF; Sheng W; Cheng WM; Ng MH; Wu BH; Yu X; Wei KR; Li FG; Lian SF; Wang PP; Quan W; Deng L; Li XH; Liu XD; Xie YL; Huang SJ; Ge SX; Huang SL; Liang XJ; He SM; Huang HW; Xia SL; Ng PS; Chen HL; Xie SH; Liu Q; Hong MH; Ma J; Yuan Y; Xia NS; Zhang J; Cao SM
Ann Oncol; 2019 Oct; 30(10):1630-1637. PubMed ID: 31373615
[TBL] [Abstract][Full Text] [Related]
18. Current understanding and management of nasopharyngeal carcinoma.
Yoshizaki T; Ito M; Murono S; Wakisaka N; Kondo S; Endo K
Auris Nasus Larynx; 2012 Apr; 39(2):137-44. PubMed ID: 21592702
[TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal carcinoma: an evolving paradigm.
Wong KCW; Hui EP; Lo KW; Lam WKJ; Johnson D; Li L; Tao Q; Chan KCA; To KF; King AD; Ma BBY; Chan ATC
Nat Rev Clin Oncol; 2021 Nov; 18(11):679-695. PubMed ID: 34194007
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.
Ji MF; Huang QH; Yu X; Liu Z; Li X; Zhang LF; Wang P; Xie SH; Rao HL; Fang F; Guo X; Liu Q; Hong MH; Ye W; Zeng YX; Cao SM
Cancer; 2014 May; 120(9):1353-60. PubMed ID: 24477877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
